Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00018291 · ClinicalTrials.gov registry record · NA
Specific Interventions for Agitation in Alzheimer's Disease
A NA study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- NA
- Development phase
NCT00018291: Completed NA study, sponsored by US Department of Veterans Affairs.
NCT00018291 is a NA study that has completed, run by US Department of Veterans Affairs. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00018291, a NA study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
This study is aimed at investigating specific pharmacological interventions in the treatment of the disruptive, agitated behavior associated with Alzheimer's patients. In addition, it is hoped that specific clinical profiles will be found to predict which treatment is most effective for these particular patients.
Interventions
- DRUG Risperidone
- DRUG Gabapentin
Trial Details
| Field | Value |
|---|---|
| Start Date | 2001-01 |
| Est. Completion | 2005-01 |
| Phase | NA |
What the finished NCT00018291 record still lists
NCT00018291 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 2 interventions - of which Risperidone is the first listed.
NCT00018291 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00018291 about?
NCT00018291 is a clinical study titled "Specific Interventions for Agitation in Alzheimer's Disease". This study is aimed at investigating specific pharmacological interventions in the treatment of the disruptive, agitated behavior associated with Alzheimer's patients. In addition, it is hoped that specific clinical profiles will be found to predict which treatment is most effective for these partic...
What is the current status of trial NCT00018291?
This trial is currently completed. It is a NA study. The study started on 2001-01. Estimated completion is 2005-01.
What interventions are being tested in trial NCT00018291?
The interventions under investigation include: Risperidone (DRUG), Gabapentin (DRUG).
Who is sponsoring clinical trial NCT00018291?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia